The present invention relates to Astrocyte Enhanced Genes (AEGs), the
expression of which is upregulated in human astrocytes grown in primary
cell cultures that are exposed to either the human immunodeficiency virus
(HIV-1) or to the HIV-1 glycoprotein gp120.